• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医学和非医学因素对医生进行艾滋病毒/艾滋病抗逆转录病毒治疗决策的影响。

Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment.

作者信息

Bogart L M, Kelly J A, Catz S L, Sosman J M

机构信息

Department of Psychology, Kent State University, Ohio 44242-0001, USA.

出版信息

J Acquir Immune Defic Syndr. 2000 Apr 15;23(5):396-404. doi: 10.1097/00126334-200004150-00006.

DOI:10.1097/00126334-200004150-00006
PMID:10866232
Abstract

To examine influences of medical factors (e.g., viral load) and nonmedical factors (e.g., patient characteristics) on treatment decisions for highly active antiretroviral therapy (HAART), we sent a survey to a random sample of 995 infectious disease physicians who treat patients with HIV/AIDS in the United States in August, 1998. The response rate was 53%. Respondents were asked to report their current practices with respect to antiretroviral treatment and the extent to which each of three medical and 17 nonmedical factors would influence them for or against prescribing HAART to a hypothetical HIV-positive patient. Most reported initiating HAART with findings of low CD4+ cell counts and high viral loads, and weighing CD4+ cell counts, viral load, and opportunistic infection heavily in their decisions to prescribe HAART. Patients' prior history of poor adherence was weighed very much against initiating HAART. Patient homelessness, heavy alcohol use, injection drug use, and prior psychiatric hospitalization were cited by most physicians as weighing against HAART initiation. Thus, most physicians in this sample follow guidelines for the use of HAART, and nonmedical factors related to patients' life situations are weighed as heavily as disease severity in treatment decisions. As HIV increasingly becomes a disease associated with economic disadvantage and other social health problems, it will be essential to develop interventions and care support systems to enable patients experiencing these problems to benefit from HIV treatment advances.

摘要

为了研究医学因素(如病毒载量)和非医学因素(如患者特征)对高效抗逆转录病毒治疗(HAART)治疗决策的影响,我们于1998年8月向美国995名治疗HIV/AIDS患者的传染病医生随机抽取的样本发送了一份调查问卷。回复率为53%。受访者被要求报告他们目前在抗逆转录病毒治疗方面的做法,以及三种医学因素和17种非医学因素中的每一种因素在多大程度上会影响他们对一名假设的HIV阳性患者开具HAART处方的支持或反对态度。大多数受访者表示,在CD4+细胞计数低和病毒载量高的情况下开始使用HAART,并在决定开具HAART处方时,非常重视CD4+细胞计数、病毒载量和机会性感染。患者先前依从性差的病史对开始使用HAART极为不利。大多数医生认为,患者无家可归、大量饮酒、注射吸毒和先前的精神科住院史不利于开始使用HAART。因此,该样本中的大多数医生遵循HAART使用指南,在治疗决策中,与患者生活状况相关的非医学因素与疾病严重程度同样重要。随着HIV越来越成为一种与经济劣势和其他社会健康问题相关的疾病,开发干预措施和护理支持系统,使经历这些问题的患者能够从HIV治疗进展中受益将至关重要。

相似文献

1
Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment.医学和非医学因素对医生进行艾滋病毒/艾滋病抗逆转录病毒治疗决策的影响。
J Acquir Immune Defic Syndr. 2000 Apr 15;23(5):396-404. doi: 10.1097/00126334-200004150-00006.
2
Physician specialization and antiretroviral therapy for HIV.医生专业化与艾滋病病毒的抗逆转录病毒疗法
J Gen Intern Med. 2003 Apr;18(4):233-41. doi: 10.1046/j.1525-1497.2003.20705.x.
3
The decision to forgo antiretroviral therapy in people living with HIV compliance as paternalism or partnership?在艾滋病毒感染者中放弃抗逆转录病毒治疗的决定:是家长式做法还是伙伴关系?
Eur J Med Res. 2004 Feb 27;9(2):61-70.
4
Relation of physician specialty and HIV/AIDS experience to choice of guideline-recommended antiretroviral therapy.医生专业与艾滋病毒/艾滋病治疗经验与指南推荐的抗逆转录病毒疗法选择之间的关系。
J Gen Intern Med. 2001 Jun;16(6):360-8. doi: 10.1046/j.1525-1497.2001.016006360.x.
5
An investigation of why eligible patients do not receive HAART.关于符合条件的患者未接受高效抗逆转录病毒治疗原因的调查。
AIDS Patient Care STDS. 2001 Apr;15(4):185-91. doi: 10.1089/10872910151133701.
6
Patterns of antiretroviral use in the United States of America: analysis of three observational databases.美国抗逆转录病毒药物的使用模式:对三个观察性数据库的分析
HIV Med. 2003 Jan;4(1):24-32. doi: 10.1046/j.1468-1293.2003.00129.x.
7
Physicians' patient base composition and mortality among people living with HIV who initiated antiretroviral therapy in a universal care setting.在普遍医疗保健环境下,开始抗逆转录病毒疗法的艾滋病毒感染者中,医生的患者群体构成和死亡率。
BMJ Open. 2019 Mar 20;9(3):e023957. doi: 10.1136/bmjopen-2018-023957.
8
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.人类免疫缺陷病毒基因耐药性检测对治疗效果的影响研究。
Verh K Acad Geneeskd Belg. 2001;63(5):447-73.
9
Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers.为注射吸毒者延迟抗逆转录病毒治疗的提供者和诊所相关因素:对北美 HIV 提供者的调查。
J Int AIDS Soc. 2012 Feb 23;15(1):10. doi: 10.1186/1758-2652-15-10.
10
Antiretroviral drug costs and prescription patterns in British Columbia, Canada: 1996-2011.加拿大不列颠哥伦比亚省 1996-2011 年抗逆转录病毒药物成本和处方模式。
Med Care. 2014 Apr;52(4):362-9. doi: 10.1097/MLR.0000000000000097.

引用本文的文献

1
Revealing the impact of social circumstances on the selection of cancer therapy through natural language processing of social work notes.通过对社会工作记录进行自然语言处理,揭示社会环境对癌症治疗选择的影响。
JAMIA Open. 2024 Oct 11;7(4):ooae073. doi: 10.1093/jamiaopen/ooae073. eCollection 2024 Dec.
2
Kidney Transplantation Contraindications: Variation in Nephrologist Practice and Training Vintage.肾移植禁忌症:肾脏病医生的实践差异与培训年限
Kidney Int Rep. 2024 Jan 19;9(4):888-897. doi: 10.1016/j.ekir.2024.01.021. eCollection 2024 Apr.
3
Improving Cancer Care for People Living With HIV: A Qualitative Study of Provider Knowledge, Attitudes, and Practice.
提高艾滋病毒感染者的癌症护理水平:提供者知识、态度和实践的定性研究。
Int J Radiat Oncol Biol Phys. 2023 May 1;116(1):60-67. doi: 10.1016/j.ijrobp.2023.01.045. Epub 2023 Jan 29.
4
Impact of Routines and Rituals on Burden of Treatment, Patient Training, Cognitive Load, and Anxiety in Self-Injected Biologic Therapy.常规与仪式对自我注射生物疗法中治疗负担、患者培训、认知负荷及焦虑的影响
Patient Prefer Adherence. 2022 Sep 19;16:2593-2607. doi: 10.2147/PPA.S375037. eCollection 2022.
5
HIV drug resistance in persons who inject drugs enrolled in an HIV prevention trial in Indonesia, Ukraine, and Vietnam: HPTN 074.在印度尼西亚、乌克兰和越南开展的一项艾滋病毒预防试验中,注射吸毒者的艾滋病毒耐药性:HPTN 074。
PLoS One. 2019 Oct 10;14(10):e0223829. doi: 10.1371/journal.pone.0223829. eCollection 2019.
6
The Longitudinal Effects of Non-injection Substance Use on Sustained HIV Viral Load Undetectability Among MSM and Heterosexual Men in Brazil and Thailand: The Role of ART Adherence and Depressive Symptoms (HPTN 063).巴西和泰国男男性行为者及异性恋男性中非注射性物质使用对持续 HIV 病毒载量不可检测的纵向影响:ART 依从性和抑郁症状的作用(HPTN 063)。
AIDS Behav. 2019 Mar;23(3):649-660. doi: 10.1007/s10461-019-02415-w.
7
Systemic Delays in the Initiation of Antiretroviral Therapy for Clinically Eligible HIV-Infected Patients in Houston, Texas: The Providers' Report Card.德克萨斯州休斯顿符合临床治疗条件的HIV感染患者开始抗逆转录病毒治疗的系统性延迟:医疗服务提供者的成绩单。
J Int Assoc Provid AIDS Care. 2018 Jan-Dec;17:2325958218774042. doi: 10.1177/2325958218774042.
8
Primary Care and Hepatology Provider-Perceived Barriers to and Facilitators of Hepatitis C Treatment Candidacy and Adherence.初级保健和肝病学提供者所感知的丙型肝炎治疗候选资格及依从性的障碍和促进因素。
Dig Dis Sci. 2017 Aug;62(8):1933-1943. doi: 10.1007/s10620-017-4608-9. Epub 2017 May 18.
9
Effects of a Laboratory Health Information Exchange Intervention on Antiretroviral Therapy Use, Viral Suppression, and Racial/Ethnic Disparities.实验室健康信息交换干预对抗逆转录病毒疗法使用、病毒抑制及种族/民族差异的影响
J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):290-298. doi: 10.1097/QAI.0000000000001385.
10
Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs.基层医疗医生为注射吸毒者开具艾滋病病毒暴露前预防药物的意愿。
AIDS Behav. 2017 Apr;21(4):1025-1033. doi: 10.1007/s10461-016-1612-6.